Study Finds 88% of Pharma Companies Base Global Launch Planning on Regulatory Affairs Guidance RESEARCH TRIANGLE PARK, NC--(Marketwired - July 20, 2016) - A new benchmarking study published by Cutting Edge Information discovered that regulatory guidance is the most common tool that...

62% of Surveyed Pharma Companies Look to C-Suite for Final Sequencing Decisions RESEARCH TRIANGLE PARK, NC--(Marketwired - July 13, 2016) - Within pharmaceutical organizations, the ultimate responsibility for approving launch sequences among 62% of companies lies with C-level...

77% of Surveyed Pharma Companies Use Ad Hoc Launch Sequencing Committees Instead of Dedicated Teams RESEARCH TRIANGLE PARK, NC--(Marketwired - June 30, 2016) - While executing a new drug launch, 77% of surveyed pharmaceutical companies look to ad hoc launch sequencing groups rather than maintaining...

62% of C-Level Executives Dominate the Approval of Pharmaceutical Launch Sequences RESEARCH TRIANGLE PARK, NC--(Marketwired - June 17, 2016) - A new study published by Cutting Edge Information found that 50% of Top 10 and Top 50 firms turn to C-level executives when planning launch...